论文部分内容阅读
我国是世界肝癌高发国之一,每年超过30万人死于肝细胞癌(HCC),占全球肝癌死亡人数的一半左右,占我国癌症死亡原因的第二位~([1])。因此,肝癌研究与临床工作正面临巨大的挑战。1慢性乙型肝炎、丙型肝炎患者需定期复查,治疗的概念需要普及,做好肝癌的早诊和筛查从全球看,至少三分之一的肝硬化是因为慢性乙肝病毒感染,其中相当部分最终会发展到肝癌~([2-3])。我国乙肝表面抗原携带率从1992年的9.75%下降至
China is one of the most developed countries in the world in liver cancer. More than 300,000 people die of hepatocellular carcinoma (HCC) every year, accounting for about half of global liver cancer deaths, accounting for the second leading cause of cancer death in China. [1] Therefore, liver cancer research and clinical work are facing enormous challenges. 1 Chronic hepatitis B, hepatitis C patients need regular review, the concept of treatment needs to be universal, do a good job in early diagnosis and screening of liver cancer Globally, at least one-third of cirrhosis is due to chronic hepatitis B virus infection, which is equivalent Some will eventually develop to liver cancer ~ ([2-3]). The carrying rate of hepatitis B surface antigen in China dropped from 9.75% in 1992 to